Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Astellas Pharma Inc. (ALPMY) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Astellas Pharma Inc. (ALPMY) - free report >>
Image: Bigstock
New Strong Sell Stocks for October 2nd
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Astellas Pharma (ALPMY - Free Report) is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. The Zacks Consensus Estimate for its current year earnings has been revised almost 21.6% downward over the last 60 days.
Barratt Developments (BTDPY - Free Report) is engaged in the business of developing residential and non-residential properties primarily in the United Kingdom. The Zacks Consensus Estimate for its current year earnings has been revised 12.1% downward over the last 60 days.
Alerus Financial (ALRS - Free Report) is a financial services company that offers financial solutions to businesses and consumers. The Zacks Consensus Estimate for its current year earnings has been revised 5.1% downward over the last 60 days.
View the entire Zacks Rank #5 List.